Quantcast

Latest Zyprexa Stories

2010-07-22 05:30:00

INDIANAPOLIS, July 22 /PRNewswire-FirstCall/ -- Nine percent revenue growth driven by higher volume continues strong trend for the year. 21 percent of Q2 revenue invested in R&D to advance pipeline of nearly 70 potential new medicines in clinical development. Ongoing cost-containment efforts support double-digit growth in operating income. Q2 earnings per share grow to $1.22 (reported), or $1.24 (non-GAAP). 2010 earnings per share guidance range raised to $4.44 to $4.59 (reported),...


Word of the Day
negawatt
  • A unit of saved energy.
Coined by Amory Lovins, chairman of the Rocky Mountain Institute as a contraction of negative watt on the model of similar compounds like megawatt.